UnitedHealth Group (NYSE:UNH) Releases FY 2020 Pre-Market Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY 2020
Pre-Market earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 16.50-16.75 for the period, compared to the Thomson Reuters consensus estimate of $16.58.

A number of brokerages recently weighed in on UNH. SVB Leerink boosted their price objective on shares of UnitedHealth Group from $360.00 to $370.00 and gave the company an outperform rating in a research report on Thursday, July 16th. Jefferies Financial Group boosted their price objective on shares of UnitedHealth Group from $283.00 to $295.00 and gave the company a hold rating in a research report on Friday, July 10th. Bank of America boosted their price objective on shares of UnitedHealth Group from $351.00 to $365.00 and gave the company a buy rating in a research report on Friday, August 28th. Oppenheimer upped their target price on shares of UnitedHealth Group from $343.00 to $353.00 and gave the stock an outperform rating in a research report on Thursday, July 16th. Finally, Citigroup upped their target price on shares of UnitedHealth Group from $339.00 to $357.00 and gave the stock a buy rating in a research report on Thursday, July 16th. Four investment analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of Buy and an average target price of $341.24.

UnitedHealth Group stock opened at $331.42 on Wednesday. The firm has a 50 day simple moving average of $310.40 and a 200-day simple moving average of $296.46. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.84 and a quick ratio of 0.84. The stock has a market capitalization of $314.96 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 1.44 and a beta of 0.68. UnitedHealth Group has a 12-month low of $187.72 and a 12-month high of $333.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Wednesday, July 15th. The healthcare conglomerate reported $7.12 EPS for the quarter, beating the consensus estimate of $5.28 by $1.84. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The business had revenue of $62.10 billion during the quarter, compared to analyst estimates of $63.54 billion. During the same period in the prior year, the business earned $3.60 earnings per share. The business’s quarterly revenue was up 2.5% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group will post 16.58 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend was Friday, September 11th. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

In related news, Director Richard T. Burke sold 10,000 shares of the stock in a transaction that occurred on Wednesday, July 22nd. The shares were sold at an average price of $303.50, for a total transaction of $3,035,000.00. Following the completion of the sale, the director now directly owns 159,215 shares of the company’s stock, valued at $48,321,752.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Marianne D. Short sold 10,336 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $312.34, for a total transaction of $3,228,346.24. Over the last three months, insiders have sold 128,522 shares of company stock valued at $39,886,448. Company insiders own 0.80% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: History of the Euro STOXX 50 Index

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply